Obesity has an impact on the efficacy of EGFR-TKI in NSCLC patients harbouring EGFR mutation: A real-world study

被引：0
|
作者：
Ding, Z-Y. [1 ]
Chen, Y-Y. [2 ]
Hong, Y. [2 ]
Tong, L-P. [2 ]
Li, Q. [2 ]
Lin, P-P. [2 ]
机构：
[1] West China Hosp, Div Biol Therapy, Chengdu, Sichuan, Peoples R China
[2] West China Hosp, Chengdu, Sichuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EGFR-TKI as neoadjuvant treatment in patients with NSCLC with EGFR sensitive mutation: A retrospective real-world analysis
    Liu, Sangtian
    Liang, Wenhua
    He, Jianxing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Retreatment with EGFR-TKI for 541 NSCLC Patients with EGFR Mutation
    Takahashi, K.
    Ito, K.
    Murotani, K.
    Asada, K.
    Okuno, M.
    Kimura, T.
    Kubo, A.
    Suda, T.
    Taniguchi, H.
    Hataji, O.
    Shindo, J.
    Kunii, E.
    Yoshida, T.
    Imaizumi, K.
    Hida, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S833 - S833
  • [3] Real world study of lung squamous cell carcinoma patients with EGFR mutation treated with EGFR-TKI
    Miao, L.
    Lin, G.
    Wu, Y.
    Chen, J.
    Ai, X.
    Yuan, M.
    Chen, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S96 - S96
  • [4] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
    Luo, Yung-Hung
    Liu, Han
    Wampfler, Jason A.
    Tazelaar, Henry D.
    Li, Yalun
    Peikert, Tobias
    Liu, Dan
    Leventakos, Konstantinos
    Chen, Yuh-Min
    Yang, Yanan
    Chiou, Shih-Hwa
    Yang, Ping
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2099 - 2114
  • [5] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
    Yung-Hung Luo
    Han Liu
    Jason A. Wampfler
    Henry D. Tazelaar
    Yalun Li
    Tobias Peikert
    Dan Liu
    Konstantinos Leventakos
    Yuh-Min Chen
    Yanan Yang
    Shih-Hwa Chiou
    Ping Yang
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2099 - 2114
  • [6] Efficacy and Toxicity of EGFR-TKI in Frail NSCLC with EGFR Mutation: A Retrospective Analysis in a Single Institution
    Akazawa, Y.
    Yoshikawa, A.
    Hashimoto, K.
    Kanazu, M.
    Yano, Y.
    Yamaguchi, T.
    Mori, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1002 - S1002
  • [7] T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Ren, Shengxiang
    Li, Wei
    Li, Aiwu
    Chen, Xiaoxia
    Gao, Guanghui
    He, Yayi
    Li, Xuefei
    Zhou, Caicun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1084 - S1084
  • [8] Real-world Efficacy of EGFR-TKI in Advanced NSCLC and Clinical Predictors of Outcome in Maharaj Nakorn Chiangmai Hospital in Thailand
    Charoentum, C.
    Nasit, K.
    Ketpueak, T.
    Suksombooncharoen, T.
    Chewaskulyong, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S409 - S409
  • [9] Real-world clinical outcomes in Chinese patients with EGFR-mutated NSCLC progressed from first-line EGFR-TKI: A prospective multicenter study
    Tian, Panwen
    Wu, Lin
    Zhou, Chengzhi
    Tan, Jie
    Wang, Ke
    Luo, Feng
    Liu, Yongmei
    Guo, Yubiao
    Li, Yinyin
    Liu, Zhe
    Gong, Youling
    Wang, Yongsheng
    Li, Weimin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients with EGFR Mutation-Positive Advanced NSCLC
    Halmos, B.
    Tan, E.
    Soo, R.
    Cadranel, J.
    Lee, M. K.
    Foucher, P.
    Hsia, T.
    Hochmair, M.
    Griesinger, F.
    Hida, T.
    Kim, E.
    Melosky, B.
    Maerten, A.
    Carcereny, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S470 - S471
12345